Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17636662 | 0.95 | KDM4E (0.41) | PTGER4KDM4EATML3MBTL1NPY5R | |
| SCHEMBL17636642 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1SMN1; SMN2KDM4A | |
| SCHEMBL21532766 | 0.91 | PTGER4 (0.38) | PTGER4KDM4EATML3MBTL1NPY5R | |
| SCHEMBL17636666 | 0.90 | KDM4E (0.41) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL17636645 | 0.89 | KDM4E (0.41) | KDM4EATML3MBTL1SMN1; SMN2KDM4A | |
| SCHEMBL13130311 | 0.88 | KDM4E (0.39) | PTGER4KDM4EATML3MBTL1NPY5R | |
| SCHEMBL21532230 | 0.88 | PTGER4 (0.34) | PTGER4KDM4EATML3MBTL1NPY5R | |
| SCHEMBL21532216 | 0.88 | PTGER4 (0.34) | PTGER4KDM4EATML3MBTL1NPY5R | |
| SCHEMBL17636879 | 0.88 | PDPK1 (0.41) | PTGER4KDM4E | |
| SCHEMBL13130308 | 0.88 | KDM4E (0.41) | PTGER4KDM4EATML3MBTL1NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | PTGER4 929/4885KDM4E 2877/4885ATM 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.